SAVE THE DATE -- 2025 VetCOT Annual Conference April 11-13, 2025 in Las Vegas!

Traumatic brain injury – A review of intravenous fluid therapy.

Pigott A, Rudloff E. Front Vet Sci 8:2021 doi: 10.3389/fvets.2021.643800

Background
  • Up to 34% of dogs & cats with blunt trauma will have head & neck injury.
  • Head trauma is significantly associated with mortality at 24-35%
Rational and Objective Treating traumatic brain injury (TBI) effectively with fluids requires understanding of blood brain barrier (BBB) & autoregulation of blood flow.
Trial Design Review article
Patient population and location Reviews 136 articles discussing fluid therapy in TBI in animals & people in hemorrhagic shock.
Methods

Reviews anatomy & physiology of normal BBB, pathophysiology at membrane level associated with disruption of BBB & effect of disruption on cerebral blood flow.

Brain Trauma Foundation does not recommend any specific fluid type.

Lund Concept discusses use of albumin & vasodilators but lacks strong evidence.

No clinical trials evaluating any fluid type in veterinary patients with hemorrhagic shock & TBI.

Discusses isotonic crystalloids, synthetic colloids, natural colloids, hyperosmolar therapy & treatments on horizon.

Endpoints (if applicable)  
Results

Isotonic crystalloids: laboratory studies showed worse brain pathology when resuscitated with isotonic crystalloids compared with any plasma product.

Synthetic colloids: faster resuscitation compared with isotonic crystalloids, less cerebral edema, both groups hypercoagulable, not as effective as plasma; no valid conclusion in 1 clinical trial.

Natural colloids: resuscitation with 4% albumin uncertain maybe because of hyperosmolality, fresh frozen plasma may help heal BBB, plasma outperforms isotonic crystalloids and synthetic colloids but depends on type of injury.

Hyperosmolar fluids (mannitol, hypertonic saline [HTS]): improvement in brain pathology when used for resuscitation, improvement in intracranial pressure (ICP) in short term but no improvement in survival or long term neurologic outcome; optimal doses unknown.

Treatments on horizon: adenosine/lidocaine/magnesium, hemoglobin-based oxygen carriers, perfluorocarbon.

Limitations Very little solid evidence; treatment algorithm proposed by authors.
Clinical Relevance Conclusions

Maximize cerebral perfusion pressure by correcting systemic hypotension. 

Lactated Ringer’s solution may be less desirable than other isotonic crystalloids.

Plasma products may lead to improved outcome.